H19 |
Antagonizes the negative regulatory factors of intestinal epithelial hyperplasia as an inflammatory lncRNA induced by IL22 |
[23] |
Participates in inflammatory diseases through VDR signaling |
[26] |
|
IFNG-AS1 |
Increases IFN-γ secretion of CD4+T cells |
[27] [28] [29] |
|
NEAT1 |
Participates in inflammatory response by regulating intestinal epithelial barrier and exocrine-mediated macrophage polarization |
[31] |
Promotes IL-8 expression by relocating SFPQ |
[32] |
Participates in TLR2-mediated expression of inflammatory cytokines |
[34] |
|
GAS5 |
Mediates intestinal mucosal by regulating the MMP expression |
[44] |
Adjusts the LPS-induced inflammatory destruction by regulating KLF 2 expression and inhibiting the NF-κB pathway |
[46] |
|
HIF1-AS2 |
Inhibits NF-κB signaling pathway activation to protect the immune barrier |
[48] |
|
CDKN2B-AS1 |
Regulates inflammation of UC by sponging miR-195-5p and miR-16-5p and is negatively correlated with levels of inflammatory cytokines |
[49] [50] |
|
HOTAIR |
Inhibits miR-218 and activates the NF-κB signaling pathway, resulting in the chemical resistance of CRC |
[61] |
Acts as a scaffold to form PRC2 complex resulting in CRC development |
[62] |
|
CRNDE |
Prevents Itch-mediated ubiquitination and degradation of RORγt to promote Th17 cell differentiation |
[71] |
|
MALAT1 |
Inhibits M2-type macrophage polarization and promotes M1-type macrophage polarization |
[73] |
Acts as miR-155 sponge to reprogram DCs into a tolerant phenotype |
[75] |
|
RPPH1 |
Stimulates CRC cell metastasis by promoting exosome-mediated macrophage M2 polarization |
[78] |
|
MEG3 |
Inhibits CRC cell invasion and migration via regulating MMP-2, MMP-9, and TIMP-2 |
[80, 81] |
Inhibits LPS-induced macrophage apoptosis and secretion of inflammatory factors |
[82] |
|
HCG14 |
Alters NOD1 expression in intestinal cells |
[87] |
|
lnc-Smad3 |
Inhibits Treg cell polarization resulting in T cell-mediated colitis |
[88] |